
Andhra Cements, OneSource Pharma, and Shree Vijay Industries Report Financial Results
Several companies announced their quarterly and annual financial results, providing key insights into the performance metrics for the period ending March 31, 2026.Andhra Cements Limited, a subsidiary of Sagar Cements Limited, reported its Statement of Financial Results for the quarter and year ended March 31, 2026.
According to the company's filings, the performance metrics are as follows:
| Particulars | Quarter ended 31. 03.2026 (Audited) | Quarter ended 31. 2025 (Un-audited) | Year ended 31.03.2026 (Audited) | Year ended 31.03.2025 (Audited) |
|---|---|---|---|---|
| Total Income | 75.483 | 8.34g | 44.249 | |
| Net Profit/(Loss) for the period before tax and exceptional items | (4,080) | (4.365) | (15,648) | (16.825) |
| Net Profit/(Loss) for the period before Tax but after Exceptional items | (4,080) | (4.991) | (15,648) | (17,451) |
| Net Profit (Loss) for the period after the period (after tax) and Other comprehensive income (after tax) | 4,871 | (5,004) | (6,708) | (15,226) |
| Equity Share Capital (Face value of Rs. 1/-) | 9,217 | |||
| Reserves excluding Retained Balance Sheet of previous year | 4.180 | 0.400 | ||
| Earning Per Share (of Rs. 10/- each) | ||||
| Basic | 5.26 | (5.41) | 17.691 | |
| Diluted | 5.26 | (5.41) | 17.29 |
OneSource Specialty Pharma Limited also disclosed its Statement of Financial Results for the quarter and year ended March 31, 2026, with figures presented in Millions.
| Particulars | Quarter ended Mar 31, 2026 (Consolidated) | Quarter ended 31. 2025 (Consolidated) | Quarter ended Mar 31, 2025 (Consolidated) | Quarter ended Mar 31, 2026 (Standalone) | Quarter ended 31, 2025 (Standalone) | Year ended Mar 31, 2026 (Standalone) | Year ended 31.2025 (Standalone) | Year ended Mar 31.2026 (Standalone) | Year ended Mar 31.2025 (Standalone) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 4,282.17 | 14,259.33 | 14,215.91 | 74,448.53 | 4,189.62 | 2.902.20 | 43,341.4 | 14,053.81 | |
| Net Profit (Loss) for the period (before Tax, Exceptional and or) | (3.25) | (859.21) | 835.02 | (820.34) | 437.79 | 198.09 | (550.95) | 1,748.77 | 266.30 |
| Net Profit/ (Loss) for the period Extraordinary items and discontinued Operations | 45.64 | (816.09) | 991.92 | (638.76) | 959.04 | 790.49 | 1,339 | 1.748.77 | 200.31 |
| Net Profit in the period after tax (after Exceptional and/ or Extraordinary items and discontinued) | 45.97 | (000.38 | 991.92 | (738.03) | (172.81) | 214.79 | (021.00) | 1,741.87 | 212.10 |
| Earning Per Share (of Rs.1/- each) | (1.63 | 15.22 |
Shree Vijay Industries Limited also presented its audited standalone financial results for the quarter and year ended March 31, 2026.
| Particulars | Quarter ended 31.03.2026 (Audited) | Quarter ended 31.12.2025 (Un-audited) | Quarter ended 31.03.2025 (Audited) | Year ended 31.03.2026 (Audited) | Year ended 31.03.2025 (Audited) |
|---|---|---|---|---|---|
| Total Income from operations (net) | |||||
| Net Profit / (Loss) before tax | -1.03 | -1.83 | -1.51 | -6.09 | -4.68 |
| Net Profit / (Loss) for the period after tax | -1.03 | -1.83 | 1.51 | -5.09 | 4.68 |
| Total Comprehensive Income for the Period and | -1.03 | -1.83 | -1.51 | -5.09 | 1468 |
| Equity Share Capital | 1409 | 7479 | 1420 | 74.25 | |
| Earnings Per Share (Face value of Rs. 10/- each) | |||||
| Basic | -0.14 | -0.63 | |||
| Diluted | -0.14 | -0.63 |
KOTAKBANK Stock Price Movement
Today, Kotak Mahindra Bank Limited shares edged higher to close at ₹383.2, marking a 1.55% gain for the day. The stock saw significant activity in post-market trading, hitting a total volume of 10.65 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.